Portal de recerca
- Inici
- Projectes i Estudis Clínics
- ESTUDIO EN FASE IIB, ABIERTO Y DE GRUPO ÚNICO DE F901318 COMO TRATAMIENTO DE INFECCIONES FÚNGICAS INVASIVAS DEBIDAS A LOMENTOSPORA PROLIFICANS,SCEDOSPORIUM SPP., ASPERGILLUS SPP. Y OTROS HONGOS RESISTENTES EN PACIENTES QUE NO DISPONEN DE OPCIONES DE TRATAMIENTO ALTERNATIVAS ADECUADAS.
ESTUDIO EN FASE IIB, ABIERTO Y DE GRUPO ÚNICO DE F901318 COMO TRATAMIENTO DE INFECCIONES FÚNGICAS INVASIVAS DEBIDAS A LOMENTOSPORA PROLIFICANS,SCEDOSPORIUM SPP., ASPERGILLUS SPP. Y OTROS HONGOS RESISTENTES EN PACIENTES QUE NO DISPONEN DE OPCIONES DE TRATAMIENTO ALTERNATIVAS ADECUADAS.
Dades bàsiques
- Protocol:
- F901318/0032
- EURDRACT:
- 2017-001290-17
- NCT:
- Centre:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Any inici:
- 2018
- Any de finalització:
- 2023
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
Candida spp. in Cetaceans: Neglected Emerging Challenges in Marine Ecosystems
Garcia-Bustos, Victor; (...); Acosta-Hernandez, Begona
Review. 10.3390/microorganisms12061128. 2024
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A clinical predictive model of candidemia by Candida auris in previously colonised critically ill patients.
Garcia-Bustos V; (...); Pemán J
Article. 10.1016/j.cmi.2020.02.001. 2020
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
de Andrés-Nogales F; (...); Martínez-Olmos J
Article. 10.1007/s41669-020-00201-2. 2020
A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
Casado, MA; (...); Grp MULTIDEX-EMD
Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.
Neurohr, Claus; (...); Behr, Juergen
Article. 10.1111/ajt.16858. 2022
A surface plasmon resonance based approach for measuring response to pneumococcal vaccine.
Garrido-Jareño M; (...); Pineda-Lucena A
Article. 10.1038/s41598-021-85958-0. 2021
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Bilton D; (...); CLEAR-108 Study Group
Article. 10.1016/j.jcf.2019.08.001. 2020
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Cardozo, C; (...); Garcia-Vidal, C
Article. 10.1093/jac/dkz491. 2020
Analysing criteria for price and reimbursement of orphan drugs in Spain.
Badia, X; (...); Tort, M
Article. 10.7399/fh.11147. 2019
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Antifibrotics and lung transplantation: A Spanish multicentre case-controlled study
Mora Cuesta, Victor Manuel; (...); Cifrian Martinez, Jose Manuel
Article. 10.1111/resp.14352. 2022
Antifungal Resistance among Less Prevalent Candida Non- albicans and Other Yeasts versus Established and under Development Agents: A Literature Review.
Espinel-Ingroff, Ana, Canton, Emilia, Peman, Javier
Review. 10.3390/jof7010024. 2021
Antimicrobial stewardship programme implementation in a medical ward
Ruiz, J; (...); Poveda, JL
Article. 2018
Aptamer-Capped nanoporous anodic alumina for Staphylococcus aureus detection
Pla, L; (...); Martinez-Manez, R
Article. 10.1016/j.snb.2020.128281. 2020
Arthritis, Pulmonary Cysts and Renal Insufficiency: COPA Syndrome.
Balaguer Cartagena MN, Fonfría Esparcia C, Anguera de Francisco G
Article. 10.1016/j.arbres.2024.04.005. 2024
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection.
Monforte, Victor; (...); Gomez-Olles, Susana
Case Reports. 10.1016/j.arbres.2021.10.002. 2022
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2018.12.027. 2019
Best practices during COVID-19 pandemic in solid organ transplant programs in Spain.
Pascual, Julio; (...); Delgado, Juan F.
Article. 10.1016/j.trre.2023.100749. 2023
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Candidemia Candida albicans clusters have higher tendency to form biofilms than singleton genotypes†.
Díaz-García J; (...); Escribano P
Article. 10.1093/mmy/myaa002. 2020
Candidemia Diagnosis With T2 Nuclear Magnetic Resonance in a PICU: A New Approach.
Cendejas-Bueno E; (...); García-Rodríguez J
Article. 10.1097/PCC.0000000000002548. 2020
Candidemia from urinary tract source: the challenge of candiduria.
Article. 10.1080/21548331.2018.1538623. 2018
Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a one health approach.
Garcia-Bustos, Victor; (...); Peman, Javier
Article. 10.1016/j.cmi.2023.03.016. 2023
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
Nogueras, A; (...); Calleja, MA
Letter. 10.1136/ejhpharm-2019-001905. 2019
Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.
Aguilar, CA; (...); Husain, S
Article. 10.1016/j.healun.2018.06.008. 2018
Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
Megias-Vericat, JE; (...); Poveda, JL
Meeting Abstract. 2020
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.
Leard LE; (...); Ramos KJ
Practice Guideline. 10.1016/j.healun.2021.07.005. 2021
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Contamination of tissue allografts from a multiorgan-multitissue donor colonized by Candida auris.
Mirabet, Vicente; (...); Peman, Javier
Article. 10.1111/tid.13535. 2020
Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting.
Kenters N; (...); Voss A
Editorial Material. 10.1016/j.ijantimicag.2019.08.013. 2019
Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].
Monzó-Gallo P; (...); Garcia-Vidal C
Correction. 10.1016/j.ijid.2024.107188. 2024
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Gironella, M.; (...); Oyaguez, I
Meeting Abstract. 2019
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
Poveda JL; (...); Torres C
Article. 10.1080/14737167.2019.1635014. 2020
COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN
Trillo, JL; (...); Torres, C
Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
Critical appraisal beyond clinical guidelines for intraabdominal candidiasis.
Maseda, Emilio; (...); Rodriguez, Alejandro
Article. 10.1186/s13054-023-04673-6. 2023
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1111/hae.13733. 2019
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
Eduardo Megias, Juan; (...); Iorio, Alfonso
Meeting Abstract. 10.1182/blood-2019-127946. 2019
Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country
Lopez-Vilella, R.; (...); Almenar Bonet, L.
Article. 2022
CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN
Lopez-Vilella, R; (...); Almenar-Bonet, L
Meeting Abstract. 2021
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1186/s13071-020-3901-1. 2020
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Cystic Fibrosis: From Salty Malediction to Possible Cure.
Sole, Amparo, Davies, Jane C., Quintana-Gallego, Esther
Editorial Material. 10.1016/j.arbres.2023.10.007. 2023
Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; (...); Pemán J
Article. 10.1128/Spectrum.00013-21. 2021
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.1080/17512433.2019.1573668. 2019
Descriptive study of malaria cases in the paediatric population in a reference hospital in Valencia, Spain, between 1993 and 2015
Cuentas, JHR; (...); Reigada, MDO
Article. 10.1016/j.anpedi.2019.03.008. 2020
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients
Ruiz-Gaitan, Alba; (...); Peman, Javier
Article. 10.1080/14787210.2019.1592675. 2019
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry.
Zvezdanova ME; (...); Vicente D
Article. 10.1016/j.cmi.2021.06.005. 2022
Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Alvarez-Roman, MT; (...); Badia, X
Article. 10.1177/2284240319880534. 2019
DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Alvarez, E.; (...); Badia, F. J.
Meeting Abstract. 2019
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
Development and electronic validation of the revised Cystic Fibrosis Questionnaire (CFQ-R Teen/Adult) New tool for monitoring psychosocial health in CF
Sole, Amparo; (...); Quittner, Alexandra L.
Article. 10.1016/j.jcf.2017.10.015. 2018
DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
Poveda, J. L.; (...); Vitoria, I
Meeting Abstract. 2019
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
Badia, X; (...); Poved, JL
Article. 10.1080/21678707.2019.1652163. 2019
Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation
Boada-Perez, Meritxell; (...); Gomez-Olles, Susana
Article. 10.3389/fimmu.2024.1445553. 2025
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Moreno-Garcia, E; (...); Garcia-Vidal, C
Article. 10.1093/ofid/ofab250. 2021
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
EFFECTS OF TEZACAFTOR/IVACAFTOR (TEZ/IVA) TREATMENT IN PATIENTS WITH CYSTIC FIBROSIS HOMOZYGOUS FOR F508DEL-CFTR: PATIENT-REPORTED OUTCOMES IN A PHASE 3 RANDOMIZED, CONTROLLED TRIAL (EVOLVE)
Yang, Y; (...); Elborn, JS
Meeting Abstract. 10.1136/thorax-2018-212555.74. 2018
EFFECTS OF TEZACAFTOR/IVACAFTOR TREATMENT IN PATIENTS WITH CYSTIC FIBROSIS AND F508DEL/F508DEL-CFTR: PATIENT-REPORTED OUTCOMES IN A PHASE 3 RANDOMIZED, CONTROLLED TRIAL
Yang, Y; (...); Elborn, J
Meeting Abstract. 2018
EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F. J.; (...); Shepherd, J.
Meeting Abstract. 2019
Evolving Indications for Heart-Lung Transplant in Spain.
Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis
Article. 10.1016/j.transproceed.2022.10.003. 2022
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease.
Carrasco Hernandez, Laura; (...); Quintana Gallego, Esther
Article. 10.1016/j.arbres.2023.05.017. 2023
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding
Albert-Mari, A; (...); Poveda-Andres, JL
Article. 10.1007/s11096-018-0714-9. 2018
EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
F, de Andres-Nogales; (...); Martinez, M.
Meeting Abstract. 2019
Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts
Bassetti M; (...); Munoz, P
Article. 10.1186/s13054-020-2793-y. 2020
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Beltran, B; (...); Nos, P
Article. 10.1159/000492626. 2019
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
Filamentous fungi in the airway of patients with cystic fibrosis: Just spectators?
Vinado, Clara; (...); Sole, Amparo
Article. 10.1016/j.riam.2021.03.005. 2021
Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme.
Guinea, Jesus; (...); Escribano, Pilar
Article. 10.1016/j.cmi.2024.07.002. 2024
Fungal burden assessment in hospital zones with different protection degrees
Garcia-Gutierrez, Laura; (...); Martin-Sanchez, Pedro M.
Article. 10.1016/j.buildenv.2024.112454. 2025
Fungal co-infection in COVID-19 patients: Should we be concerned?
Pemán J; (...); Quindós G
Review. 10.1016/j.riam.2020.07.001. 2020
Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies
Candel, FJ; (...); Peman, J
Review. 10.1016/j.riam.2019.09.001. 2020
Fungal microbiota dynamics and its geographic, age and gender variability in patients with cystic fibrosis.
Martinez-Rodriguez, Sara; (...); Horra C
Article. 10.1016/j.cmi.2022.11.001. 2022
Gene Expression Profiling and Pathway Enrichment Analysis in Long-Term Survivors after Lung Transplantation with Normal Allograft Function
Saez-Gimenez, B; (...); Roman, A
Meeting Abstract. 2020
Gene Expression Profiling and Pathway Enrichment Analysis in Long-Term Survivors after Lung Transplantation with Normal Allograft Function
Saez-Gimenez, B; (...); Roman, A
Meeting Abstract. 2021
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Genomic characterization of MRSA recovered from people with cystic fibrosis during two Spanish multicentre studies (2013 and 2021).
Maruri-Aransolo A; (...); Caballero-Pérez JD
Article. 10.1093/jacamr/dlae160. 2024
Genotyping Reveals High Clonal Diversity and Widespread Genotypes of Candida Causing Candidemia at Distant Geographical Areas
Guinea, J; (...); Escribano, P
Article. 10.3389/fcimb.2020.00166. 2020
Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation.
Mondejar-Lopez, Pedro; (...); Sanchez-Solis, Manuel
Article. 10.1016/j.rmed.2022.106736. 2022
Giant Circumflex Aneurysm with Arteriovenous Fistula Surgery Guided by Three-dimensional Printing.
Blanco-Herrera OR; (...); Montero-Argudo JA
Editorial Material. 10.1016/j.athoracsur.2019.11.051. 2020
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato.
Serrano-Lobo J; (...); ASPEIN Study Group
Article. 10.1111/myc.13541. 2022
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella
Garcia-Bustos, Victor; (...); Ruiz-Sauri, Amparo
Article. 10.1080/22221751.2021.2017756. 2022
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
Human papilloma virus DNA detection in clinical samples using fluorogenic probes based on oligonucleotide gated nanoporous anodic alumina films.
Hernández-Montoto A; (...); Martínez-Máñez R
Article. 10.1002/adhm.202203326. 2023
Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris
de Oliveira, HC; (...); Zaragoza, O
Article. 10.3389/fcimb.2019.00083. 2019
Identification of the Most Immunoreactive Antigens of Candida auris to IgGs from Systemic Infections in Mice.
Areitio M; (...); Ramirez-Garcia A
Article. 10.1021/acs.jproteome.3c00752. 2024
IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients.
Vallejo, Carlos; (...); Peman, Javier
Article. 10.3390/jof9060628. 2023
IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1007/s00430-022-00759-0. 2023
Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia
Claverias, L.; (...); Rodriguez, A.
Article. 10.1016/j.medin.2021.12.005. 2022
Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia.
Claverias L; (...); Rodríguez A
Article. 10.1016/j.medine.2021.12.013. 2022
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
Impact of Lung Function Decline on Mortality in Lung Transplant Recipients: Long-Term Results From the L-CsA-i Study for the Prevention of Bronchiolitis Obliterans Syndrome.
Kneidinger, Nikolaus; (...); Neurohr, Claus
Article. 10.3389/fmed.2022.897581. 2022
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
Mondejar-Lopez, P; (...); de la Cruz, OA
Article. 10.1016/j.rmed.2020.106062. 2020
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL
Article. 10.7399/fh.11262. 2020
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Quindós G; (...); Eraso E
Article. 10.3389/fcimb.2022.906563. 2022
In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida auris.
Caballero U; (...); Jauregizar N
Article. 10.3390/pharmaceutics13111767. 2021
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
Rodríguez-Veiga R; (...); Sanz GF
Article. 10.1007/s00277-019-03744-5. 2019
Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.
García-Ortega A; (...); Martínez-García MÁ
Article. 10.1016/j.jinf.2021.01.003. 2021
Individualized antifungal therapy in critically ill patients with invasive fungal infection
Zaragoza, R, Maseda, E, Peman, J
Article. 10.1016/j.riam.2021.04.006. 2021
Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Bastida, G; (...); Nos, P
Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12842. 2019
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
Invasive fungal infection in crtically ill patients: hurdles and next challenges
Jose, P; (...); Zaragoza, R
Article. 10.1080/1120009X.2018.1557799. 2019
Invasive scedosporiosis in lung transplant recipients: A nine-year retrospective study in a tertiary care hospital.
Ibáñez-Martínez E; (...); Pemán J
Case Reports. 10.1016/j.riam.2021.06.002. 2021
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP
Article. 10.1136/ejhpharm-2020-002322. 2020
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements.
Crespo MM; (...); Budev M
Practice Guideline. 10.1016/j.healun.2021.07.014. 2021
Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study.
Law N; (...); Husain S
Article. 10.1016/j.healun.2019.06.007. 2019
Lack of evidence for infectious SARS-CoV-2 in feces and sewage
Albert, Sandra; (...); Domingo-Calap, Pilar
Article. 10.1007/s10096-021-04304-4. 2021
Lack of relationship between genotype and virulence in Candida species.
Díaz-García J; (...); Escribano P
Article. 10.1016/j.riam.2020.10.002. 2021
Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19
Bekki, Amina; (...); Angel Martinez-Garcia, Miguel
Meeting Abstract. 10.1183/13993003.congress-2021.OA2597. 2021
Liposomal amphotericin B: thirty years of a highly effective therapy for the treatment of invasive mycoses
Peman, J, Quindos, G
Editorial Material. 10.1016/j.riam.2021.04.007. 2021
Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.
Bilton, Diana; (...); CLEAR-110 Study Group
Article. 10.1016/j.jcf.2021.05.013. 2021
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods
Espinel-Ingroff, A; (...); Tejada, M
Article. 10.1128/AAC.01651-18. 2019
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
Microbiological assessment of arterial allografts processed in a tissue bank
Mirabet, V.; (...); Peman, J.
Article. 10.1007/s10561-021-09951-7. 2021
Microbiological diagnosis of invasive mycosis
Garcia, J, Peman, J
Review. 10.1016/j.riam.2018.05.003. 2018
Mobilisation Mechanism of Pathogenicity Islands by Endogenous Phages in Staphylococcus aureus clinical strains.
Cervera-Alamar, M; (...); Tormo-Mas, MA
Article. 10.1038/s41598-018-34918-2. 2018
Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)
Alastruey-Izquierdo, A; (...); GEMICOMED SEIMC REIPI
Article. 10.1128/AAC.00358-18. 2018
Molecular identification of Candida auris by PCR amplification of species-specific GPI protein-encoding genes
Ruiz-Gaitan, AC; (...); de Groot PWJ
Article. 10.1016/j.ijmm.2018.06.014. 2018
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: A multicenter prospective study
Sarmiento, E; (...); Carbone, J
Article. 10.1016/j.healun.2018.04.001. 2018
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
Multiresistant organisms: bacteria and beyond.
Article. 10.1097/MOT.0000000000000976. 2022
Nanoemulsion Increases the Antifungal Activity of Amphotericin B against Four Candida auris Clades: In Vitro and In Vivo Assays.
Marena, Gabriel Davi; (...); Peman, Javier
Article. 10.3390/microorganisms11071626. 2023
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
Near-normal aerobic capacity in long-term survivors after lung transplantation.
Saez-Gimenez B; (...); Ojanguren I
Article. 10.1183/23120541.00381-2020. 2021
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
Non-Invasive Infections Diagnosis in Lung Transplant Recipients in Exhaled Breath Condensate
Ibanez-Martinez, E.; (...); Sole-Jover, A.
Meeting Abstract. 2021
Novel Chromogenic Medium CHROMagar TM Candida Plus for Detection of Candida auris and Other Candida Species from Surveillance and Environmental Samples: A Multicenter Study.
Mulet Bayona, Juan Vicente; (...); Gimeno Cardona, Concepcion
Article. 10.3390/jof8030281. 2022
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Oligonucleotide-capped nanoporous anodic alumina biosensor as diagnostic tool for rapid and accurate detection of Candida auris in clinical samples.
Pla, Luis; (...); Santiago-Felipe, Sara
Article. 10.1080/22221751.2020.1870411. 2020
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data
Ruiz-Gaitan, AC; (...); Peman, Javier
Article. 10.1016/j.ijantimicag.2019.02.005. 2019
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy
Margusino-Framiñán L; (...); Morillo-Verdugo R
Article. 10.7399/fh.11498. 2020
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
Vericat, JEM; (...); Iorio, A
Meeting Abstract. 2020
Position paper: Models of post-transplant care for individuals with cystic fibrosis.
McKone, Edward; (...); Pilewski, Joseph M.
Article. 10.1016/j.jcf.2023.02.011. 2023
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Article. 10.1080/10428194.2018.1474462. 2019
Potential Fungal Zoonotic Pathogens in Cetaceans: An Emerging Concern
Garcia-Bustos, Victor; (...); Rosario Medina, Inmaculada
Review. 10.3390/microorganisms12030554. 2024
Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study.
Monforte V; (...); Gómez-Ollés S
Article. 10.1016/j.arbr.2020.12.012. 2021
Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study.
Monforte, Victor; (...); Gomez-Olles, Susana
Article. 10.1016/j.arbres.2020.12.024. 2021
Pregnancy and fertility in people with cystic fibrosis following lung transplantation.
Taylor-Cousar JL, Sole A, Jain R
Article. 10.1097/MCP.0000000000001117. 2024
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
Recent changes in candidemia trends in a tertiary hospital (2011-2018).
Piqueras, Ana I; (...); Peman, Javier
Article. 10.1016/j.riam.2020.09.005. 2020
Recomendaciones GEMICOMED/GEIRAS-SEIMC para el manejo de las infecciones y colonizaciones por Candida auris.
Alastruey-Izquierdo A; (...); en nombre de GEMICOMED GEIRAS-SEIMC
Abstract of Published Item. 10.1016/j.riam.2019.06.001. 2019
Risk assessment of arterial allograft contamination from tissue donors colonized by Candida auris.
Mirabet V; (...); Pemán J
Article. 10.1016/j.jhin.2021.03.003. 2021
Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease
Remuzgo-Martinez, S; (...); Gonzalez-Gay, MA
Article. 10.3390/biomedicines9050458. 2021
Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.
Monzo-Gallo, Patricia; (...); Garcia-Vidal, Carolina
Article. 10.1016/j.ijid.2024.107070. 2024
SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines
Esteve-Sanchez, Yoel; (...); Climent, Estela
Article. 10.1016/j.snb.2024.136378. 2024
SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.
Lopez-Palacios, Alba; (...); Climent, Estela
Article. 10.1016/j.snr.2025.100298. 2025
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
Selective and Sensitive Probe Based in Oligonucleotide-Capped Nanoporous Alumina for the Rapid Screening of Infection Produced by Candida albicans.
Ribes À; (...); Martinez-Manez, R
Article. 10.1021/acssensors.9b00169. 2019
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Study of pediatric invasive pneumococcal disease in the 13-pneumococcal conjugated vaccine era.
Garrido-Jareno, Marta; (...); Peman, Javier
Article. 10.1016/j.diagmicrobio.2024.116532. 2024
Supervised Domain Adaptation for Automated Semantic Segmentation of the Atrial Cavity
Saiz-Vivo, Marta; (...); Naranjo, Valery
Article. 10.3390/e23070898. 2021
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
T2Candida (R) to guide antifungal and lengh of treatment of candidemia in a pediatric multivisceral transplant recipient
Falces-Romero, I; (...); Garcia-Rodriguez, J
Article. 10.1016/j.mmcr.2018.05.006. 2018
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The Ecology of Non-Candida Yeasts and Dimorphic Fungi in Cetaceans: From Pathogenicity to Environmental and Global Health Implications.
Garcia-Bustos, Victor; (...); Rosario Medina, Inmaculada
Article. 10.3390/jof10020111. 2024
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Marques MR; (...); Mangas-Sanjuan V
Article. 10.1111/apa.14944. 2020
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Treatment failure with anti-CGRP therapy: should we discontinue the treatment or switch it?
Castellanos, CN; (...); Insa, SD
Meeting Abstract. 2021
Treatment failure with anti-CGRP therapy: should we discontinue the treatment or switch it?
Castellanos, CN; (...); Insa, SD
Meeting Abstract. 2021
Triplex Hybridization-Based Nanosystem for the Rapid Screening of Pneumocystis Pneumonia in Clinical Samples.
Pla, Luis; (...); Santiago-Felipe, Sara
Article. 10.3390/jof6040292. 2020
Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin.
Solé A; (...); Bravo C
Article. 10.1016/j.arbres.2019.10.013. 2020
Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Bejar, S; (...); Mateu, PN
Meeting Abstract. 2020
Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy
Garcia, SV; (...); Andres, JLP
Article. 10.1016/j.yrtph.2018.10.002. 2018
USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Dominguez Hernandez, L.; (...); Gomez Segui, I
Meeting Abstract. 2019
Usefulness of Chromogenic Media with Fluconazole Supplementation for Presumptive Identification of Candida auris.
Ruiz-Gaitan, Alba; (...); Peman, Javier
Article. 10.3390/diagnostics13020231. 2023
Usefulness of guideline recommendations for prognosis in patients with candidemia.
Cuervo G; (...); REIPI, the GEMICOMED (SEIMC) and the Spanish CANDI-Bundle Group
Article. 10.1093/mmy/myy118. 2019
Utility of two PCR-RFLP-based techniques for identification of Candida parapsilosis complex blood isolates.
Marcos-Arias C; (...); Eraso E
Article. 10.1111/myc.13061. 2020
Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients
Rodriguez-Veiga, Rebeca; (...); Sanz, Miguel A.
Article. 10.1111/myc.12891. 2019
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.
Garcia-Bustos V; (...); Pemán J
Article. 10.3390/microorganisms9102177. 2021